Postoperative intensity-modulated radiation therapy for cancers of the paranasal sinuses, nasal cavity, and lacrimal glands: Technique, early outcomes, and toxicity Journal Article


Authors: Hoppe, B. S.; Wolden, S. L.; Zelefsky, M. J.; Mechalakos, J. G.; Shah, J. P.; Kraus, D. H.; Lee, N.
Article Title: Postoperative intensity-modulated radiation therapy for cancers of the paranasal sinuses, nasal cavity, and lacrimal glands: Technique, early outcomes, and toxicity
Abstract: Background. Our aim was to review Memorial Sloan-Kettering Cancer Center's experience with postoperative intensity-modulated radiotherapy (IMRT) for paranasal sinus, nasal cavity, and lacrimal gland cancer and report dosimetric measures, toxicity, and outcomes. Methods. Between September 2000 and June 2006, 37 patients with paranasal sinus, nasal cavity, or lacrimal gland cancer underwent postoperative IMRT. Median values were as follows: prescription dose, 60 Gy (range, 50-70); PTVD95, 99% (range, 79-101%); optic nerve Dmax, 53 Gy (range, 2-54); optic chiasm Dmax, 51 Gy (range, 2-55). Acute and late toxicities were scored by Radiation Therapy Oncology Group morbidity criteria. Results. Median follow-up was 28 months. Two-year local progression-free and overall survivals were 75% and 80%. No early- or late-grade 3/4 radiation-induced ophthalmologic toxicity occurred. Conclusions. Preliminary results show that adjuvant IMRT in these patients is feasible, allowed for excellent planning target volume (PTV) coverage, and minimized dose delivered to optic structures. Longer follow-up is warranted to assess the extent of late effects and outcomes. ©2008 Wiley Periodicals, Inc.
Keywords: adolescent; adult; cancer chemotherapy; clinical article; treatment outcome; treatment response; aged; middle aged; survival analysis; cancer surgery; survival rate; retrospective studies; overall survival; intensity modulated radiation therapy; cancer growth; treatment planning; cancer adjuvant therapy; cancer patient; cancer radiotherapy; disease free survival; postoperative care; radiation dose; radiotherapy, adjuvant; cancer staging; follow up; follow-up studies; antineoplastic agent; cancer grading; radiotherapy dosage; radiotherapy; morbidity; radiation injury; risk assessment; kaplan-meiers estimate; survival time; imrt; radiotherapy, intensity-modulated; dosimetry; probability; fluorodeoxyglucose f 18; computer assisted emission tomography; radiation injuries; therapy effect; radiotherapy planning, computer-assisted; paranasal sinus cancer; paranasal sinus neoplasms; paranasal sinus; nose neoplasms; nasal cavity; eye neoplasms; lacrimal gland; lacrimal gland tumor; nose cavity cancer; lacrimal apparatus
Journal Title: Head & Neck
Volume: 30
Issue: 7
ISSN: 1043-3074
Publisher: John Wiley & Sons, Inc.  
Date Published: 2008-07-01
Start Page: 925
End Page: 932
Language: English
DOI: 10.1002/hed.20800
PUBMED: 18302261
PROVIDER: scopus
DOI/URL:
Notes: --- - "Cited By (since 1996): 12" - "Export Date: 17 November 2011" - "CODEN: HEANE" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Michael J Zelefsky
    754 Zelefsky
  2. Dennis Kraus
    268 Kraus
  3. Suzanne L Wolden
    560 Wolden
  4. Nancy Y. Lee
    871 Lee
  5. Bradford Scott Hoppe
    14 Hoppe
  6. Jatin P Shah
    721 Shah